Determination of Pre/Post Treatment Changes in Prostate Specific Antigen Levels in Patients with Acute Prostatitis
Journal Title: Translational Research in Urology - Year 2022, Vol 4, Issue 1
Abstract
Introduction: Given that studies on the association between pre/post-treatment PSA levels in acute prostatitis are limited and investigations in men from different communities are few, the present study aimed to determine the pre/post-treatment changes in the prostate-specific antigen (PSA) levels in patients with acute prostatitis. Method: The current cross-sectional study was conducted in 2020 on a population of men with acute prostatitis. The patients were then referred to a laboratory to measure PSA levels for a definitive diagnosis of acute prostatitis. Prostate volume was determined using ultrasound. Afterward, drug treatment was started for the patient, followed by monitoring. The PSA levels were re-measured, and prostate volume was recorded after treatment. Patient information included patient profile, age, date of the first visit, PSA level at the baseline (before treatment), diagnosis of acute prostatitis, time to start treatment, time to end treatment, PSA level after treatment, and prostate volume. Results: The mean and standard deviation of the age of these patients was 59.90±6.31 years old. The results showed a significant relationship between age and primary PSA at the beginning of diagnosis and PSA reduction. (P-value<0.05). There is a significant relationship between age and duration of treatment (P-value=0.001). The duration of treatment was significantly related to the reduction of PSA, the amount of primary PSA at the beginning of diagnosis, and the amount of secondary PSA after treatment (P-value<0.05). Conclusion: The study's findings can be concluded that the duration of treatment can effectively reduce the level of PSA in patients with acute prostatitis. Extensive studies with a control group for future studies are recommended. Graphical Abstract
Authors and Affiliations
Hamid Mazdak; Zahra Zandi Mashhadi; Kia Nouri Mahdavi; Reza Kazemi
Keywords
Related Articles
- EP ID EP704307
- DOI 10.22034/TRU.2022.323475.1097
- Views 96
- Downloads 0
Urolithiasis in Renal Transplantation Patients: An Update of the Literature
Urolithiasis is rare in renal transplant patients (<1%). The reasons are multifactorial such as metabolic, medications, and recurrent urinary tract infections. The stones are usually found incidentally on imaging; 50% of...
Comparison on Diagnostic Accuracy of Prostate Cancer Detection Tools: A Systematic Review and Meta-Analysis
Introduction Some tests and markers have proved to improve the diagnosis of prostate cancer (PCa). This meta-analysis aimed to review the diagnostic accuracy of three commercial tests, prostate health index (PHI), prost...
Landscape of Circular Ribonucleic Acids in Urological Cancers
Urological malignancies are among the most important neoplastic diseases imposing a significant burden on health care systems globally. The current therapeutic measures for these cancers have unsatisfactory results, and...
Potassium Citrate as a Preventive Treatment for Double-J Stent Encrustation: A Randomized Clinical Trial
Introduction: This research was conducted to assess whether prophylactic citrate potassium can reduce double-J stent encrustation in patients with urolithiasis. Methods: In the present study, 70 patients with urolithias...
Homeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy
Introduction Current hemostatic agents are needed to reduce bleeding and transfusion during several surgery processes. Plant-based absorbable surgical hemostatic agents (microporous polysaccharide hemospheres) are propo...